The prevalence of celiac disease (CD) varies greatly, potentially because of incomplete ascertainment of cases and small study samples with limited statistical power. Previous reports indicate that the incidence of CD is increasing. We examined the prevalence of CD in a well-defi ned US county.
INTRODUCTION
Celiac disease (CD) is a chronic immune-mediated disease characterized by small intestinal infl ammation ( 1 ) . Triggered by gluten exposure in genetically sensitive individuals ( 2 ) , this disease is associated with excess mortality, as well as a number of complications, including type 1 diabetes ( 3 ) and lymphoproliferative disease ( 4, 5 ) . Th ese and other high-risk groups, such as anemia, osteoporosis, and irritable bowel syndrome, have been identifi ed ( 6 ) and patients in these risk groups are increasingly tested for CD. Even so, the prevalence of diagnosed CD is low. In a recent European multicenter study, the prevalence of diagnosed CD was 0.18 % ; however, if Finland is excluded, where awareness is especially high, only 0.07 % of the population had been diagnosed with CD ( 7 ) . Most previous American data indicate a true overall CD prevalence based on screening of about or slightly < 1 % ( 8 -12 ) .
Prevalence studies based exclusively on serologic CD screening oft en report higher fi gures ( 6 ) . However, real diff erences may also exist between regions ( 7 ) and races, as higher levels of CD have also been shown outside Europe and the United States among populations of predominantly European extraction (e.g., New Zealand and Australia) ( 13, 14 ) .
Some prevalence data imply a true increase in CD or celiac autoimmunity over time ( 15 -17 ) , but data are scarce on the actual incidence of CD ( 18, 19 ) . Such data are important in that temporal trends in CD incidence could provide insight into the environmental factors that trigger CD, as well as serve in planning for the health care needs of CD patients. For instance, the " Swedish epidemic, " with a sudden increase in CD incidence ( 20 ) , helped identify the interplay between gluten introduction and breastfeeding as important for the risk of CD in early age ( 21 ) . In this regard, we previously documented a strong increase in CD incidence in one US county in the 1990s ( 18 ) but it is unknown whether this increase was transient. Th e primary aim of this study was to estimate the incidence of CD in Olmsted County, Minnesota between 2000 and 2010.
METHODS

Setting
Olmsted County is situated in the upper Midwest, where whites make up over 85 % of the population ( 22 ) . Th is community is ideally suited for epidemiologic studies because the Rochester Epidemiologic Project collects essentially all data on medical care for Olmsted County residents, focusing on the two major providers of health care in the community: the Mayo Clinic and its component hospitals (Saint Mary ' s and Rochester Methodist) along with the Olmsted Medical Center with its affi liated community hospital and outpatient clinics. Th is medical records linkage system, which has been described elsewhere ( 23 ) , was used in our previous paper on CD trends in the area ( 18 ) . Using the infrastructure of the Rochester Epidemiologic Project, comprehensive (inpatient and outpatient) community medical records, together with CD serology and histopathology data, were reviewed to estimate the incidence of diagnosed CD in this well-defi ned geographic region. Because of this unique medical records linkage system, complete ascertainment of diagnosed CD cases is possible.
Several data sources were used to identify patients with CD: the Rochester Epidemiologic Project medical index, as was used in previous studies ( 9, 18, 24 ) , active recruitment of patients known to be undergoing assessment and potential diagnosis of the disease at the time of their clinical visit, and the electronic medical record (the Mayo Clinic Life Sciences System, begun in 1994), which also contains information on disease symptoms, histopathology records, and serology data. We also reviewed the patient charts of all individuals with a diagnosis of either CD (International Classifi cation of Disease (code)-9: 579.0) or dermatitis herpetiformis (International Classifi cation of Disease (code)-9: 694.0).
All of the above searches included a check for Olmsted County residency based on zip codes. As the county boundary passes through some small towns, the patient ' s street address was reviewed in some instances to determine if he or she lived within Olmsted County.
Data collection
Following approval by the Institutional Review Boards of Mayo Clinic and the Olmsted Medical Center, one coauthor (C.T.v.D.) extracted data on CD from the clinical records and then classifi ed patients according to age, sex, classical symptoms (presence of diarrhea or weight loss) ( 25 ) , and year of diagnosis. In accordance with Minnesota law, patients who declined to provide authorization for the use of their medical records for research purposes were not included in this study (or any other medical study).
Statistical analyses
Incidence rates of clinically diagnosed CD were estimated using the number of new cases in each age-, sex-, and calendar year-specifi c stratum as the numerator, with corresponding denominators derived from annual census fi gures for Olmsted County, assuming the entire population was at risk ( 22 ) . Age-and sex-adjusted incidence rates were computed based on direct standardization against the 2000 US white population. We estimated 95 % confi dence intervals (CIs) assuming the Poisson distribution for number of cases. Multiple variable Poisson regression was used to examine the association of age, sex, and calendar year with incidence rates. Measured per individual year, both age and calendar year were fi t as continuous variables in the modeling process, with smoothing loess plots applied to assess their functional form. For brevity, we tabulated incidence rates in Table 2 according to age categories (0 -3, 4 -18, 19 -44, 45 -64, and 65 years) and periods of 3-year intervals (except for the fi rst 2 years, 2000 -01, which overlap with our previously published incidence study) ( 18 ) . A logistic regression model (using a generalized logit link function) was employed to assess the association of calendar year on the proportion of incidence cases presenting with classical symptoms (diarrhea with or without weight loss ( 25 ) ) over the study period, adjusted for age and sex. Th e diff erent models used were selected based on simple plots of the data in order to refl ect the observed patterns in the data.
All analyses were performed using SAS / STAT soft ware, version 9.2 (SAS Institute, Cary, NC). A two-sided alpha level of 0.05 was used to determine statistical signifi cance.
RESULTS
Study subjects
From 2000 to 2010, 249 individuals were diagnosed with CD in Olmsted County. Some 22 of these had been identifi ed through our family screening study in 2001 -05 ( 26 ) . Of the 249, 157 (63 % ) were females. Th e median age at diagnosis was 37.9 (range, 1.2 -84.9 years). Concerning presenting symptoms, 79 (32 % ) patients had diarrhea and 25 (10 % ) had weight loss, although only 14 (6 % ) had both diarrhea and weight loss at CD diagnosis and were, therefore, classifi ed as having " classical " CD.
Of the 248 individuals with more extensive data available on symptoms, 99 (40 % ) had abdominal pain / cramping, 69 (28 % ) had anemia, 41 (17 % ) suff ered from malaise, and 36 reported nausea / vomiting (15 % ). A positive family history for CD was seen in 72 individuals (29 % ). Of individuals tested for either tissue transglutaminase or endomysial antibodies, 89 % (166 / 187) were positive for at least one of these antibodies. Supplementary Table 1 shows the prevalence of CD in Olmsted county on 1 January, 2010.
Temporal trends in CD incidence
Th e overall age-and sex-adjusted incidence of clinically diagnosed CD over the study period was 17. smooth of incidence rate was plotted against calendar year to explore the linearity of their relationship. As the incidence of CD appeared to increase in the fi rst several years and then fl atten aft er that ( Figure 2 , thin solid line), a model that assumed a linear increase from years 2000 to 2004 and a leveling off thereaft er ( Figure 2 , thick dashed line) was eventually adopted. Based on a comparison of log-likelihood statistics, the model with this two-slope time trend provided a signifi cantly better fi t of the data than a model with a linear (one-slope) time eff ect ( P = 0.021).
In the two-slope model, a higher incidence of CD was associated with female sex ( P < 0.001) and increasing age ( P = 0.034). Over the entire period, the age-adjusted incidence of CD in females and males was 21.3 (95 % CI = 18.0 -24.7) and 13.6 (95 % CI = 10.8 -16.5) per 100,000 p-y, respectively ( P < 0.001, adjusted for age and calendar year eff ects) ( Figure 3 ), the incidence of CD tended to be highest in the older age groups (45 -64 years and 65 -85 years). Controlling for sex and calendar year eff ects, the CD incidence rate increased about 6.5 % (95 % CI = 0.5 % -12.8 % ) per 10-year increment in age ( P = 0.034).
CD incidence according to patient characteristics
Neither the percentage nor the incidence of CD characterized by diarrhea without weight loss increased signifi cantly over the study period ( P = 0.557 and 0.136, respectively, adjusted for age and sex) ( Table 2 ). In contrast, and as illustrated in Figure 4 , the proportion of cases presenting with both diarrhea and weight loss decreased signifi cantly over time (15 % in 2000 -2001 down to 3 % in 2008 -2010, P = 0.044), although this did not result in a significant drop in the incidence of classical CD over the study period ( P = 0.168).
DISCUSSION
Th is study is potentially the most complete assessment of the recent incidence of CD in a North-American population. Between 2000 and 2010, some 249 individuals were diagnosed with CD in Olmsted County. Th e corresponding overall incidence was 17.4 per 100,000 p-y, which, to our knowledge, is one of the highest fi gures reported anywhere in a carefully enumerated population that includes both adults and children. Adding to this, our recent National Health and Nutrition Examination Survey data showing Age-specifi c results summarized with count and incidence rates (per 100,000 person-years, unadjusted), while bolded across-all-age results are described with the age-adjusted (and sex-adjusted for " Total " section) incidence rates and 95 % confi dence intervals. a Rate=incidence rate per 100,000 person-years adjusted to the US white population in 2000.
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an overall prevalence of CD of 0.71 % in the United States ( 11 ), it is evident that CD is swift ly becoming a major health problem in this country. Although earlier eff orts have been made to identify CD through screening of risk groups ( 8 ) and certain age strata ( 9 ), as well as through screening in a primary care setting ( 27 ) or in connection with upper endoscopy ( 28, 29 ) , few studies ( 18 ) have used an integrative approach to determine the incidence of CD. We found that the previously described increase in CD incidence (0.9 per 100,000 p-y in the 1960s, rising to 3.3 per 100,000 p-y in the 1990s) has not abated ( 18 ) . As documented in the present study, the incidence of CD has continued to rise since then but seems to have leveled off at about 20 per 100,000 p-y aft er 2004. Although the high (and increasing) incidence may partly be explained by high physician awareness and large-scale eff orts to screen at-risk groups (increasing detection rate), we believe that other factors have a substantial role since the rising incidence in the 1990s, when serological screening tools (e.g., endomysial and tissue transglutaminase antibodies) became readily available, was not followed by a drop in incidence aft er 2000, as would be expected if the Olmsted County population had merely been swept of unrecognized prevalent CD cases. Still we cannot rule out that external factors infl uenced case-fi nding. For instance it is possible that the publication of the fi rst major US study of celiac seroprevalence in 2003 ( 8 ) led to heightened awareness of CD and contributed to the rise in CD incidence seen in 2004 -2006. Several studies have shown changing incidence in CD ( 15 -17,19,20 ) . Considering the predominance of a Caucasian population in Olmsted County now, as in the 1950s, the rise of CD cannot be explained by a change in the underlying genetic makeup of the community. Instead, an environmental factor(s) is likely. As we ( 19, 30 ) and others ( 31 ) have found an association between infectious disease (especially gastroenteritis) and CD, a changing pattern in infections may have contributed to the rise in CD in Olmsted County. Another explanation concerns amount, timing and frequency of gluten consumption. For instance, Ivarsson et al. ( 21 ) reported that high amounts of gluten increased the risk of CD. Unfortunately, we have no data on gluten consumption in individuals from Olmsted County, although gluten Frequency of classical symptoms in CD cases summarized with counts and percentages, and tested for a temporal trend using a generalized logit model after adjusting for age and gender. Incidence described with age-adjusted (and sex-adjusted for bolded " Total " results) incidence rates and 95 % confi dence intervals (per 100,000 person-years adjusted to the US white population in 2000), with rates tested for a temporal trend via Poisson regression after adjusting for age and gender.
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providers in the area should virtually guarantee that we have identifi ed all cases with diagnosed CD. Moreover, we had access not only to clinical registers but also to serology and histopathology data to ascertain patients. Finally, the large number of diagnosed cases means that we could better estimate the incidence rates (i.e., calculate narrow CIs). Th is study has some limitations that need to be considered when interpreting the results. Th e predominant population of Olmsted County consists of non-Hispanic whites and thus the number of Hispanics, Blacks and Asians are limited. We cannot, therefore, extrapolate our fi ndings to these latter populations. CD has a marked predominance among non-Hispanic whites and may be less common among other minority groups ( 11 ) . We were also unable to determine the relative incidence of both diagnosed and undiagnosed CD as this was not a screening study . Finally, Olmsted County is dominated by the Mayo Clinic, enriched foods (e.g., pizza, bagels, and high-protein and high-fi ber bread) are increasingly ingested in the United States ( 32 ) . In contrast to Swedish data showing very high incidence rates in children < 2 years of age between 1985 and 1995 (about 200 per 100,000 p-y) ( 20 ), we found a low incidence of CD in young US children. Interestingly, however, high incidence fi gures in the most recent period (2008 -2010) were noted in the age groups born in the years of the Swedish epidemic (late 1980s and early 1990s) ( 33 ) . Th erefore, we cannot rule out that the same environmental factors have been present both in Sweden and in the United States.
Th e majority of newly diagnosed CD patients were females. Th is sex pattern is consistent with previous data ( 34, 35 ) . Th e female predominance is noteworthy given that population-based screening in our area has previously found a more neutral female -male ratio ( 9, 11 ) . Some data suggest that sex aff ects the clinical presentation of CD ( 36, 37 ) , with women more oft en diagnosed with CD, whereas men remain undiagnosed. During their fertile years, women are also more likely to encounter health care and incidentally be diagnosed with CD.
Previous data from our center ( 18 ) and elsewhere ( 38 ) have otherwise established that classical CD (diarrhea and weight loss) has become less prominent. Th e current study was able to confi rm that the proportion of newly diagnosed patients with both diarrhea and weight loss decreased from 2000 to 2010 but the absolute incidence of diarrhea-associated CD did not decrease. Th is observation suggests that the lower proportion of diarrhea in CD patients is probably due to testing of new risk groups ( 39 ) , such as patients with other immune-mediated diseases ( 40, 41 ) or osteoporosis ( 42 ) , fi rst-degree relatives ( 26 ) , or a more extensive use of CD serology to identify early onset patients before classical symptoms can develop. Yet, the persistence of a steady rate of more classic disease may suggest that the true incidence of CD may be increasing.
Th e main strength of this paper is its population-based design. Th e well-established collaboration between the major health care 
